Recently, a mutation in trans-2, 3-enoyl-CoA reductase-like (TECRL) gene, coded for endoplasmic reticulum (ER) protein, was first identified in CPVT patients5. The gene discussed is TECRL; the disease is catecholaminergic polymorphic ventricular tachycardia.